• Expert comment: AMG 510 KRAS inhibitor trial results – ‘A good start’ (with Colin Lindsay)

  • 2019/10/07
  • 再生時間: 4 分
  • ポッドキャスト

Expert comment: AMG 510 KRAS inhibitor trial results – ‘A good start’ (with Colin Lindsay)

  • サマリー

  • Colin Lindsay discusses the trial results for AMG 510 – a novel inhibitor targeting the KRAS G12C mutation –  in patients with locally advanced or metastatic non-small-cell lung cancer.

    Find more on Medicine Matters oncology

    More from WCLC 2019

    続きを読む 一部表示

あらすじ・解説

Colin Lindsay discusses the trial results for AMG 510 – a novel inhibitor targeting the KRAS G12C mutation –  in patients with locally advanced or metastatic non-small-cell lung cancer.

Find more on Medicine Matters oncology

More from WCLC 2019

Expert comment: AMG 510 KRAS inhibitor trial results – ‘A good start’ (with Colin Lindsay)に寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。